Structural and Biophysical Characterization of C-Glycosylic 1,2-Thiodisaccharides Reveals Determinants of Selective Binding to Galectin-7 and Galectin-8N
(2026) In ChemMedChem 21(16).- Abstract
- Achieving isoform selectivity within the galectin family remains a central challenge in glycomimetic drug design due to the highly conserved architecture of their carbohydrate recognition domains. Here, we define the structural and thermodynamic basis of recognition of a series of C-glycosylic 1,2-thiodisaccharides targeting human galectin-7 and the N-terminal domain of galectin-8 (galectin-8N). Using an integrated approach combining fluorescence polarization, isothermal titration calorimetry, and high-resolution X-Ray crystallography, we establish a clear structure–activity relationship across the ligand series. Compound 17 emerges as the most potent galectin-8N ligand (Kd = 13 μM), outperforming thiodigalactoside, while... (More)
- Achieving isoform selectivity within the galectin family remains a central challenge in glycomimetic drug design due to the highly conserved architecture of their carbohydrate recognition domains. Here, we define the structural and thermodynamic basis of recognition of a series of C-glycosylic 1,2-thiodisaccharides targeting human galectin-7 and the N-terminal domain of galectin-8 (galectin-8N). Using an integrated approach combining fluorescence polarization, isothermal titration calorimetry, and high-resolution X-Ray crystallography, we establish a clear structure–activity relationship across the ligand series. Compound 17 emerges as the most potent galectin-8N ligand (Kd = 13 μM), outperforming thiodigalactoside, while compound 13 shows preferential binding to galectin-7, demonstrating tunable isoform bias. Structural analysis reveals a conserved anchoring mechanism in which the β-galactoside unit (Gly-1) drives affinity through a rigid hydrogen-bonding and π-stacking network, whereas the second sugar (Gly-2) modulates potency by adopting distinct orientations in galectin-specific extended binding sites. Notably, ligand binding converges on conserved motifs while leaving nonconserved regions unexploited, highlighting clear opportunities for structure-guided optimization. Collectively, this work establishes C-glycosylic thiodisaccharides as a robust platform for selective galectin targeting and provides actionable design principles for next-generation inhibitors. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3d760b51-210a-469a-9d96-1912fb7143cd
- author
- organization
- publishing date
- 2026-08-27
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Galectins/metabolism, Humans, Structure-Activity Relationship, Crystallography, X-Ray, Disaccharides/chemistry, Binding Sites, Thermodynamics, Protein Binding, Ligands, Models, Molecular, Molecular Structure
- in
- ChemMedChem
- volume
- 21
- issue
- 16
- article number
- e70439
- pages
- 13 pages
- publisher
- Wiley-Blackwell
- external identifiers
-
- scopus:105047425016
- pmid:42603778
- ISSN
- 1860-7187
- DOI
- 10.1002/cmdc.70439
- language
- English
- LU publication?
- yes
- additional info
- © 2026 The Author(s). ChemMedChem published by Wiley‐VCH GmbH.
- id
- 3d760b51-210a-469a-9d96-1912fb7143cd
- date added to LUP
- 2026-08-20 17:22:45
- date last changed
- 2026-09-28 12:05:43
@article{3d760b51-210a-469a-9d96-1912fb7143cd,
abstract = {{Achieving isoform selectivity within the galectin family remains a central challenge in glycomimetic drug design due to the highly conserved architecture of their carbohydrate recognition domains. Here, we define the structural and thermodynamic basis of recognition of a series of C-glycosylic 1,2-thiodisaccharides targeting human galectin-7 and the N-terminal domain of galectin-8 (galectin-8N). Using an integrated approach combining fluorescence polarization, isothermal titration calorimetry, and high-resolution X-Ray crystallography, we establish a clear structure–activity relationship across the ligand series. Compound 17 emerges as the most potent galectin-8N ligand (<i>K</i><sub>d</sub> = 13 μM), outperforming thiodigalactoside, while compound 13 shows preferential binding to galectin-7, demonstrating tunable isoform bias. Structural analysis reveals a conserved anchoring mechanism in which the β-galactoside unit (Gly-1) drives affinity through a rigid hydrogen-bonding and π-stacking network, whereas the second sugar (Gly-2) modulates potency by adopting distinct orientations in galectin-specific extended binding sites. Notably, ligand binding converges on conserved motifs while leaving nonconserved regions unexploited, highlighting clear opportunities for structure-guided optimization. Collectively, this work establishes C-glycosylic thiodisaccharides as a robust platform for selective galectin targeting and provides actionable design principles for next-generation inhibitors.}},
author = {{Tsagkarakou, Anastasia S. and Kantsadi, Anastassia L. and Theodoridou, Vasiliki I. and Veliotis, Nikolaos and Lázár, László and József, János and Juhász, László and Kontopidis, George and Leffler, Hakon and Nilsson, Ulf J. and Somsák, László and Leonidas, Demetres D.}},
issn = {{1860-7187}},
keywords = {{Galectins/metabolism; Humans; Structure-Activity Relationship; Crystallography, X-Ray; Disaccharides/chemistry; Binding Sites; Thermodynamics; Protein Binding; Ligands; Models, Molecular; Molecular Structure}},
language = {{eng}},
month = {{08}},
number = {{16}},
publisher = {{Wiley-Blackwell}},
series = {{ChemMedChem}},
title = {{Structural and Biophysical Characterization of C-Glycosylic 1,2-Thiodisaccharides Reveals Determinants of Selective Binding to Galectin-7 and Galectin-8N}},
url = {{http://dx.doi.org/10.1002/cmdc.70439}},
doi = {{10.1002/cmdc.70439}},
volume = {{21}},
year = {{2026}},
}
